UK joins Novartis flu ban; Crucell vaccine suspended too
This article was originally published in Scrip
Executive Summary
The UK's MHRA (Medicines and Healthcare products Regulatory Agency) has asked Novartis to recall two batches of its Agrippal seasonal influenza vaccine, following action begun in Italy earlier this month after Novartis reported quality defects with the vaccine. The various European national agencies that have asked for precautionary recalls of the vaccine have emphasized that there is no current indication of a safety issue with the vaccines.